[ET Net News Agency, 18 July 2019] China Biotech Services Holdings Limited (08037) said
its subsidiary Shanghai Longyao Biotech Company Limited (Shanghai Longyao) has entered
into a strategic cooperation agreement with GE Medical Systems Trade and Development
(Shanghai) Co. Ltd.
The parties will jointly develop customised, modularised and closed-system automatic
production process for autologous and allogenic cell therapeutics. As a biotech company
mainly focuses on the chimeric antigen receptor T (CAR-T) cell therapeutics, this
cooperation will help Shanghai Longyao to accelerate the process from research and
development to industrialisation.
The strategic cooperation agreement is valid for three years. (RC)